Kevin F Boehnke
Overview
Explore the profile of Kevin F Boehnke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stains E, Kennalley A, Tian M, Boehnke K, Kraus C, Piper B
Mayo Clin Proc Innov Qual Outcomes
. 2025 Mar;
9(2):100590.
PMID: 40066150
Objective: To compare the 2017 National Academies of Sciences, Engineering, and Medicine cannabis report to state medical cannabis (MC) laws defining approved qualifying conditions (QC) from 2017 and 2024 and...
2.
Fleege N, Loeffler B, Boehnke K, Henry N
Clin Breast Cancer
. 2025 Feb;
PMID: 40021432
Introduction: Cannabidiol (CBD) is a phytocannabinoid found in the plant Cannabis sativa and is thought to have broad potential therapeutic value. Little is reported on CBD use in patients with...
3.
Glynos N, Baker A, Aday J, Kruger D, Boehnke K, Lake S, et al.
Br J Pain
. 2025 Feb;
:20494637251319497.
PMID: 39944237
Psychedelic substances have shown preliminary efficacy for several neuropsychiatric disorders and are currently being investigated for chronic pain conditions. However, few studies have investigated outcomes of naturalistic psychedelic use among...
4.
Kruger D, Albrecht J, Aday J, Barron J, Herberholz M, Boehnke K
J Psychoactive Drugs
. 2025 Feb;
:1-7.
PMID: 39907623
Psychedelic drugs are currently being explored for their therapeutic potential for a variety of health conditions. The recent increased public interest in psychedelics necessitates empirical investigation into motivations for use...
5.
Boehnke K, Bowyer G, McAfee J, Smith T, Klida C, Kurtz V, et al.
J Cannabis Res
. 2025 Jan;
7(1):7.
PMID: 39856785
Introduction: Chronic pain is common among Veterans, some of whom use cannabis for pain. We conducted a feasibility pilot study of a novel coaching intervention to help Veterans optimize use...
6.
Bergmans R, Yu C, Yalavarthi B, Xiao L, Wegryn-Jones R, Summerville J, et al.
Cannabis Cannabinoid Res
. 2024 Nov;
PMID: 39582441
Veterans use cannabis as a chronic pain treatment due to a combination of the easing of restrictions and dissatisfaction with care standards. The segregation of medical cannabis from conventional health...
7.
Boehnke K, Kruger D, Cuttler C, Doucette M, Wilson-Poe A
J Psychoactive Drugs
. 2024 Nov;
:1-10.
PMID: 39570774
Presently, 24 states have legalized adult use (recreational) cannabis, each following medical-only access. Although states that pass adult use laws report substantial declines in the number of registered medical patients,...
8.
Boehnke K, Sinclair R, Gordon F, Roehler D, Smith T, Hoots B
Am J Public Health
. 2024 Oct;
114(S8):S685-S693.
PMID: 39442022
To investigate characteristics of data reported in US medical cannabis registries across states. Data included 2021 medical cannabis registry reports from 34 states, Puerto Rico, and the District of Columbia...
9.
Boehnke K, Smith T, Elliott M, Wilson-Poe A, Kruger D
J Cannabis Res
. 2024 Oct;
6(1):38.
PMID: 39354586
Introduction: The Department of Health and Human Services recently recommended rescheduling cannabis from Schedule I to Schedule III, which might have broad effects on public health outcomes related to cannabis....
10.
Glynos N, Baker A, Aday J, Pouyan N, Barron J, Herberholz M, et al.
J Psychoactive Drugs
. 2024 Sep;
:1-11.
PMID: 39297183
Psychedelic-assisted therapy (PAT) has shown preliminary efficacy for psychiatric and physical health conditions. Although some people report naturalistic psychedelic use with so-called "underground" practitioners, little is known about PAT that...